{
  "retracted": false,
  "timestamp": 1551398400000,
  "updates": [
    {
      "timestamp": 1585074076355,
      "identifier": {
        "doi": "10.2337/dc19-er03"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.2337/dc16-1371"
  },
  "publisher": "American Diabetes Association",
  "title": "Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042â€“2050"
}
